9SD1
The R62Q clinical variant of human bisphosphoglycerate mutase (hBPGM).
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE MASSIF-3 |
| Synchrotron site | ESRF |
| Beamline | MASSIF-3 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2023-07-03 |
| Detector | DECTRIS EIGER X 4M |
| Wavelength(s) | 0.9677 |
| Spacegroup name | P 1 |
| Unit cell lengths | 37.550, 47.242, 143.043 |
| Unit cell angles | 86.86, 84.12, 83.17 |
Refinement procedure
| Resolution | 71.080 - 2.500 |
| R-factor | 0.2107 |
| Rwork | 0.208 |
| R-free | 0.26360 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.542 |
| Data reduction software | xia2 |
| Data scaling software | Aimless (0.7.4) |
| Phasing software | MOLREP (11.9.02) |
| Refinement software | PHENIX ((1.21.2_5419: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 71.080 | 2.600 |
| High resolution limit [Å] | 2.500 | 2.500 |
| Rmerge | 0.194 | 0.757 |
| Rmeas | 0.247 | 0.966 |
| Rpim | 0.151 | 0.591 |
| Total number of observations | 84866 | 9455 |
| Number of reflections | 31472 | 3531 |
| <I/σ(I)> | 3.2 | 1.1 |
| Completeness [%] | 93.9 | |
| Redundancy | 2.7 | 2.7 |
| CC(1/2) | 0.951 | 0.513 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.09 M NPS (0.3M Sodium Nitrate, 0.3 Sodium Phosphate dibasic, 0.3M Ammonium Sulfate), 0.1 M of Buffer System2 (Sodium HEPES; MOPS (acid)) pH 7.5, 30 % v/v of Precipitant Mix 1 (40% v/v PEG 500* MME; 20 % w/v PEG 20000) |






